Story
S&P/TSX Composite Ends Flat as Sector Gains Offset Broader Declines

Summary
Canada's benchmark stock index ended Monday's session virtually unchanged, as strength in the healthcare and consumer staples sectors was countered by a larger number of declining stocks.
Canada's main stock index, the S&P/TSX Composite, finished Monday's trading session nearly flat, posting a marginal gain of just 0.01%. The narrow advance came as strength in specific sectors managed to offset broader market weakness.
Market Internals Show Mixed Picture
Despite the flat close for the benchmark index, market breadth was negative. According to data from Investing.com, falling stocks on the Toronto Stock Exchange outnumbered advancing ones by a margin of 563 to 415, with 72 issues ending unchanged. This indicates that the session's slight gain was not broadly supported across the market.
Investor sentiment, as measured by the S&P/TSX 60 VIX, pointed to lower expected volatility. The index, which tracks the implied volatility of S&P/TSX Composite options, fell 0.77% to 14.10.
Sector and Stock Movers
The session was primarily supported by gains in the Consumer Staples, Healthcare, and Telecoms sectors. Standout performers included:
Ad- Thomson Reuters Corp (TSX:TRI): rose 8.90% to close at 146.94.
- Curaleaf Holdings Inc (TSX:CURA): added 5.72% to end at 14.05.
- Descartes Systems Group Inc (TSX:DSG): was up 5.55% to 111.16.
On the other side of the ledger, significant declines were seen in shares of Celestica Inc. (TSX:CLS), which fell 8.44%, and Hammond Power Solutions Inc (TSX:HPSa), which dropped 7.64%.
Commodities and Currencies
Commodity markets, a key driver for the resource-heavy TSX, presented a mixed picture. Crude oil prices advanced, with the October contract for West Texas Intermediate rising 1.85% to $101.90 a barrel. However, precious metals faced pressure, as December Gold Futures fell 1.60% to $4,338.45 a troy ounce.
In foreign exchange markets, the Canadian dollar was little changed against the U.S. dollar. Meanwhile, the U.S. Dollar Index Futures, which measures the greenback against a basket of major currencies, gained 0.38%.
Read next
More on Stocks
BOJ Rate Hike Nears, Pitting Japanese Financials Against Exporters
The Bank of Japan is widely expected to raise its key interest rate to a 31-year high this week, a move that is creating a sharp divide in the stock market between beneficiaries like banks and sectors facing pressure, such as exporters.

Genscript Biotech Stock Surges Over 16% on Eli Lilly AI Partnership
Shares in the Hong Kong-listed biotech firm rallied after announcing a collaboration with Eli Lilly's AI-powered drug discovery platform, a move supported by a recent capital raise focused on AI infrastructure.

Volkswagen's Seat Brand Faces Discontinuation Amid Chinese EV Pressure
Volkswagen is reportedly set to phase out its historic Spanish brand, Seat, as part of a major restructuring to combat rising competition from Chinese automakers and focus investment on its profitable, all-electric Cupra marque.

Hong Kong Biotech Sector Shows Stark Divide as Biocytogen, Genscript Post Major Gains
A small group of companies, led by Biocytogen Pharmaceuticals and Genscript Biotech, have delivered substantial one-year returns, highlighting a sharp performance gap within Hong Kong's 52-stock biotech universe where most firms remain unprofitable.